Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Surgery Partners stock in Canada | $58.53

How to buy Surgery Partners stock in Canada | $58.53

Surgery Partners, Inc
-$0.71 (-1.28%)

Surgery Partners is a medical care facilities business based in the US. Surgery Partners stocks (SGRY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $61.61 – an increase of 8.65% over the previous week. Surgery Partners employs 9,100 staff and has a trailing 12-month revenue of around $1.9 billion.

How to buy Surgery Partners stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: SGRY in this case.
  5. Research Surgery Partners stocks. The platform should provide the latest information available.
  6. Buy your Surgery Partners stocks. It's that simple.

How has Coronavirus impacted Surgery Partners's stock price?

Since the stock market crash in March caused by coronavirus, Surgery Partners's stock price has had significant positive movement.

Its last market close was $58.53, which is 68.29% up on its pre-crash value of $18.56 and 1,363.25% up on the lowest point reached during the March crash when the stocks fell as low as $4.

If you had bought $1,000 worth of Surgery Partners stocks at the start of February 2020, those stocks would have been worth $319.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $3,450.93.

Surgery Partners stock price

Use our graph to track the performance of SGRY stocks over time.

Surgery Partners stocks at a glance

Information last updated 2021-07-30.
Latest market close$58.53
52-week range$15.21 - $69.58
50-day moving average $62.0749
200-day moving average $48.4081
Wall St. target price$66.67
Dividend yield N/A (0%)
Earnings per share (TTM) $-5.044

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Surgery Partners stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Surgery Partners price performance over time

Historical closes compared with the last close of $58.53

1 month (2021-07-01) -10.23%
3 months (2021-04-30) 21.43%

Is Surgery Partners under- or over-valued?

Valuing Surgery Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Surgery Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Surgery Partners's PEG ratio

Surgery Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.66. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Surgery Partners's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Surgery Partners's EBITDA

Surgery Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$307.6 million.

The EBITDA is a measure of a Surgery Partners's overall financial performance and is widely used to measure a its profitability.

Surgery Partners financials

Revenue TTM USD$1.9 billion
Operating margin TTM 10.82%
Gross profit TTM USD$379.8 million
Return on assets TTM 2.43%
Return on equity TTM 1.17%
Profit margin -5.67%
Book value $5.757
Market capitalisation USD$4.6 billion

TTM: trailing 12 months

How to short and sell Surgery Partners stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "SGRY.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.8 million Surgery Partners stocks held short by investors – that's known as Surgery Partners's "short interest". This figure is 14.5% down from 2.1 million last month.

There are a few different ways that this level of interest in shorting Surgery Partners stocks can be evaluated.

Surgery Partners's "short interest ratio" (SIR)

Surgery Partners's "short interest ratio" (SIR) is the quantity of Surgery Partners stocks currently shorted divided by the average quantity of Surgery Partners stocks traded daily (recently around 432188.6746988). Surgery Partners's SIR currently stands at 4.15. In other words for every 100,000 Surgery Partners stocks traded daily on the market, roughly 4150 stocks are currently held short.

However Surgery Partners's short interest can also be evaluated against the total number of Surgery Partners stocks, or, against the total number of tradable Surgery Partners stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Surgery Partners's short interest could be expressed as 0.02% of the outstanding stocks (for every 100,000 Surgery Partners stocks in existence, roughly 20 stocks are currently held short) or 0.0813% of the tradable stocks (for every 100,000 tradable Surgery Partners stocks, roughly 81 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Surgery Partners.

Find out more about how you can short Surgery Partners stock.

Surgery Partners stock dividends

We're not expecting Surgery Partners to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Surgery Partners stock price volatility

Over the last 12 months, Surgery Partners's stocks have ranged in value from as little as $15.21 up to $69.58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surgery Partners's is 3.1801. This would suggest that Surgery Partners's stocks are significantly more volatile than the average for this exchange and represent a higher risk.

Surgery Partners overview

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site